Halfan

Active Ingredient(s): Halofantrine
FDA Approved: * July 24, 1992
Pharm Company: * GLAXOSMITHKLINE
Category: Malaria

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Halfan Overview

Halofantrine is a drug used to treat malaria. Halofantrine's structure contains a substituted phenanthrene, and is related to the antimalarial drugs quinine and lumefantrine. Marketed as Halfan, halofantrine is never used to prevent malaria and its mode of action is unknown, although a crystallographic study showed that it binds to hematin in vitro, suggesting a possible mechanism of action.[1] Halofantrine has also been shown to bind to plasmpesin, a haemoglobin degrading enz...

Read more Halfan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Halofantrine

Recent Halfan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Halofantrine or a similar ingredient: (1 result)

• HALOFANTRINE